Thane Wettig
2020
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $122,158 |
| Option Awards | $2,159,568 |
| Salary | $263,258 |
| Stock Awards | $1,262,400 |
| Other | $47,610 |
| Total | $4,004,993 |
Wettig received $2.2M in option awards, accounting for 54% of the total pay in 2020.
Wettig also received $150K in bonus, $122.2K in non-equity incentive plan, $263.3K in salary, $1.3M in stock awards and $47.6K in other compensation.
Rankings
In 2020, Thane Wettig's compensation ranked 2,849th out of 13,090 executives tracked by ExecPay. In other words, Wettig earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,849 out of 13,090 | 78th |
Division Manufacturing | 1,097 out of 5,620 | 81st |
Major group Chemicals And Allied Products | 405 out of 2,253 | 82nd |
Industry group Drugs | 349 out of 1,953 | 82nd |
Industry Pharmaceutical Preparations | 255 out of 1,458 | 83rd |
Pay ratio
| Thane Wettig's Pay | $4,004,993 |
|---|---|
| Median Employee's Pay | $177,952 |
| Pay Ratio | 23to 1 |
In 2020, the annual total compensation of Thane Wettig was $4,004,993.
The annual total compensation of the median employee at FibroGen was $177,952.
The ratio of Thane Wettig's pay to the pay of median employee was therefore 23 to one.
Wettig's colleagues
We found seven more compensation records of executives who worked with Thane Wettig at FibroGen in 2020.
2020
Enrique Conterno
FibroGen
Chief Executive Officer
2020
Mark Eisner
FibroGen
Chief Medical Officer
2020
K Yu
FibroGen
Chief Medical Officer
2020
Pat Cotroneo
FibroGen
Chief Financial Officer
2020
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2020
Christine Chung
FibroGen
Senior Vice President, China Operations
2020
James Schoeneck
FibroGen